MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$1,699M
Free Cash flow
$1,991M
Unit: Million (M) dollars
Positive Cash Flow Breakdown
Other, net
Net earnings
Amortization of intangible asset...
Others
Negative Cash Flow Breakdown
Repayments of long-term debt
Dividends paid
Purchases of common shares
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net earnings
928
1,077
1,776
1,644
Depreciation
402
381
370
371
Amortization of intangible assets
658
422
422
420
Share-based compensation
168
317
113
120
Investing and financing losses, net
-
-
-65
-
Trade receivables
386
42
-222
202
Inventories
301
420
-234
-213
Prepaid expenses and other assets
-
-
1,295
-
Trade accounts payable and other liabilities
-
-
954
-
Income taxes
-
-
-5
-
Other, net
-1,019
-39
-
-221
Net cash from operating activities
2,488
1,315
3,315
2,787
Acquisitions of property and equipment
497
399
689
496
Acquisitions of businesses and technologies, net of cash acquired
164
19,798
20
55
Proceeds from business dispositions
-
-
0
0
Purchases of investment securities
-
-
167
-
Proceeds from sales of investment securities
-
-
3
-
Sales (purchases) of other investment securities, net
26
207
-
-90
Other
-14
-34
-6
-4
Net cash from (used in) investing activities
-673
-20,324
-913
-457
Net borrowings (repayments) of short-term debt and other
64
31
-71
8
Proceeds from issuance of long-term debt and debt with maturities over 3 months
-
-
5
-
Proceeds from issuance of long-term debt
-33
19,857
-
0
Repayments of long-term debt and debt with maturities over 3 months
-
-
1,504
-
Repayments of long-term debt
1,405
-87
-
501
Purchases of common shares
1,045
180
302
305
Proceeds from stock options exercised
3
116
5
69
Dividends paid
1,102
1,098
1,030
1,031
Other
0
-
0
0
Net cash from (used in) financing activities
-3,518
17,313
-1,397
-1,760
Effect of exchange rate changes on cash and cash equivalents
4
-23
6
-10
Net increase (decrease) in cash and cash equivalents
-1,699
-1,719
1,011
560
Cash and cash equivalents, beginning of year
6,803
8,522
6,532
6,532
Cash and cash equivalents, end of period
5,104
6,803
8,522
7,511
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Other, net
-$1,019M
(-517.62%↓ Y/Y)
Net earnings
$928M
(-47.84%↓ Y/Y)
Amortization of intangible
assets
$658M
(56.67%↑ Y/Y)
Depreciation
$402M
(12.61%↑ Y/Y)
Share-based compensation
$168M
(18.31%↑ Y/Y)
Net cash from
operating activities
$2,488M
(21.54%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
$4M
(-92.16%↓ Y/Y)
Canceled cashflow
$687M
Net increase
(decrease) in cash and cash...
-$1,699M
(-505.49%↓ Y/Y)
Canceled cashflow
$2,492M
Net borrowings
(repayments) of short-term...
$64M
(500.00%↑ Y/Y)
Proceeds from stock
options exercised
$3M
(-91.43%↓ Y/Y)
Other
-$14M
(-600.00%↓ Y/Y)
Trade receivables
$386M
(-5.85%↓ Y/Y)
Inventories
$301M
(10133.33%↑ Y/Y)
Net cash from (used
in) financing...
-$3,518M
(-220.69%↓ Y/Y)
Canceled cashflow
$67M
Net cash from (used
in) investing...
-$673M
(-15.64%↓ Y/Y)
Canceled cashflow
$14M
Repayments of long-term
debt
$1,405M
(140400.00%↑ Y/Y)
Dividends paid
$1,102M
(7.09%↑ Y/Y)
Purchases of common shares
$1,045M
(17316.67%↑ Y/Y)
Proceeds from issuance of
long-term debt
-$33M
(-1750.00%↓ Y/Y)
Acquisitions of property and
equipment
$497M
(-1.00%↓ Y/Y)
Acquisitions of businesses
and technologies,...
$164M
(446.67%↑ Y/Y)
Sales (purchases) of
other investment...
$26M
(-50.00%↓ Y/Y)
Buy us a coffee
Abbott_Laboratories_logo-svg
ABBOTT LABORATORIES (ABT)
Abbott_Laboratories_logo-svg
ABBOTT LABORATORIES (ABT)
Show more